Moreover, targeting CCL2 decreased the recruitment of both tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) to the tumor site and reduced primary tumor growth [54]. This evidence concerns the gene CCL2 and neoplasm.